Cassava Sciences Inc vs Vipshop Holdings Ltd - ADR — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Vipshop Holdings Ltd - ADR trades at $15.06 (market cap $7.40B). The key difference: Vipshop Holdings Ltd - ADR is far larger — about 155× Cassava Sciences Inc's market cap, and Vipshop Holdings Ltd - ADR pays a 4.02% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | VIPS | |
|---|---|---|
Market Cap | $47.75M | $7.40B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.64 | $20.68 |
52-Week Low | $0.87 | $12.92 |
Enterprise Value | -$34.93M | $3.97B |
Dividend Yield | — | 4.02% |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.995, up 3.75% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of -$0.18 beating expectations of -$0.225. Financials show negative cash flows and profitability, with ROE at -55.79% and net income of -$90.97M in 2025. Analyst consensus is strongly positive with 8 buy ratings out of 12.
Despite operational losses, FLNA's consistent earnings beats and strong analyst support suggest potential upside if clinical developments progress. Key risks include sustained cash burn, lack of revenue, and dependence on successful drug trials for Tuberous Sclerosis Complex. The stock remains speculative with high volatility expected.
Vipshop Holdings (VIPS) trades at $15.68, up 1.75% with a bullish technical signal. The stock shows attractive valuation metrics including a P/E of 7.1 and P/S of 0.5, while maintaining solid profitability with 7.07% net margin and 18.43% ROE. Recent Q1 2026 earnings met expectations, and the company is pursuing growth through outlet store strategies. Analyst consensus leans bullish with 53.57% buy ratings.
The outlook remains constructive given discounted valuation and operational efficiency, though revenue stagnation and competitive pressures in China's e-commerce sector present challenges. Positive cash flow generation and strategic initiatives support potential upside, but investors should monitor execution on growth initiatives amid economic headwinds.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →